227 related articles for article (PubMed ID: 22572984)
1. Desensitization effect of preseasonal seven-injection allergoid immunotherapy with olive pollen on basophil activation: the efficacy of olive pollen-specific preseasonal allergoid immunotherapy on basophils.
Gokmen NM; Ersoy R; Gulbahar O; Ardeniz O; Sin A; Unsel M; Kokuludag A
Int Arch Allergy Immunol; 2012; 159(1):75-82. PubMed ID: 22572984
[TBL] [Abstract][Full Text] [Related]
2. Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?
Kepil Özdemir S; Sin BA; Güloğlu D; İkincioğulları A; Gençtürk Z; Mısırlıgil Z
Int Arch Allergy Immunol; 2014; 164(3):237-45. PubMed ID: 25170594
[TBL] [Abstract][Full Text] [Related]
3. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of two preseasonal regimens of glutaraldehyde modified, tyrosine-adsorbed parietaria pollen extract over a period of three years in monosensitive patients.
Negro JM; Wheeler AW; Hernández J; Youlten LJ; Pascual A; García-Sellés FJ; Pagán JA; López-Sánchez JD; Miralles JC; Sarrió F; Milán JM; Contreras LG; Vidal D
Allergol Immunopathol (Madr); 1999; 27(3):153-64. PubMed ID: 10431101
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
Ceuppens JL; Bullens D; Kleinjans H; van der Werf J;
Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
Guerra F; Daza JC; Almeda E
J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395
[TBL] [Abstract][Full Text] [Related]
9. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.
Van Overtvelt L; Baron-Bodo V; Horiot S; Moussu H; Ricarte C; Horak F; Zieglmayer P; Zieglmayer R; Montagut A; Galvain S; de Beaumont O; Le Gall M; Moingeon P
Allergy; 2011 Dec; 66(12):1530-7. PubMed ID: 21883279
[TBL] [Abstract][Full Text] [Related]
10. [Hyposensitization in pollinosis. Results of a 3-year controlled study with 2 depot-allergoid grass pollen extracts: aluminum hydroxide-adsorbed allergoid and tyrosine-adsorbed allergoid].
Mühlethaler K; Wüthrich B; Peeters AG; Terki N; Girard JP; Frank E
Schweiz Rundsch Med Prax; 1990 Apr; 79(14):430-6. PubMed ID: 2188335
[TBL] [Abstract][Full Text] [Related]
11. The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent.
Worm M; Ernst D; Kraller M; Babina M
Int Arch Allergy Immunol; 2017; 172(1):20-26. PubMed ID: 28219062
[TBL] [Abstract][Full Text] [Related]
12. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G-dependent changes in basophil allergen threshold sensitivity during birch pollen immunotherapy.
Lalek N; Kosnik M; Silar M; Korosec P
Clin Exp Allergy; 2010 Aug; 40(8):1186-93. PubMed ID: 20528883
[TBL] [Abstract][Full Text] [Related]
14. Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid.
Pfaar O; Hohlfeld JM; Al-Kadah B; Hauswald B; Homey B; Hunzelmann N; Schliemann S; Velling P; Worm M; Klimek L
Clin Exp Allergy; 2017 Nov; 47(11):1445-1455. PubMed ID: 28696503
[TBL] [Abstract][Full Text] [Related]
15. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
16. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis.
Klimek L; Dormann D; Jarman ER; Cromwell O; Riechelmann H; Reske-Kunz AB
Clin Exp Allergy; 1999 Oct; 29(10):1326-35. PubMed ID: 10520053
[TBL] [Abstract][Full Text] [Related]
17. Date palm pollen allergoid: characterization of its chemical-physical and immunological properties.
Mistrello G; Harfi H; Roncarolo D; Kwaasi A; Zanoni D; Falagiani P; Panzani R
Int Arch Allergy Immunol; 2008; 145(3):224-30. PubMed ID: 17914274
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid.
Corrigan CJ; Kettner J; Doemer C; Cromwell O; Narkus A;
Allergy; 2005 Jun; 60(6):801-7. PubMed ID: 15876311
[TBL] [Abstract][Full Text] [Related]
19. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
[TBL] [Abstract][Full Text] [Related]
20. Rush sublingual immunotherapy in Parietaria allergic patients.
D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]